Estrogens as Potential Therapeutic Agents in Multiple Sclerosis

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 87-94

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor Agonists as Potential Therapeutic Agents in Multiple Sclerosis

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1129-1135

Bentham Science Publishers

Access to resources Recommend Favorite

Preactive Multiple Sclerosis Lesions Offer Novel Clues for Neuroprotective Therapeutic Strategies

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 68-81

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Agents in Multiple Sclerosis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 14, Iss. 1, 2015-03 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic developments in multiple sclerosis

By Goodin D.S.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 655-670

Informa Healthcare

Access to resources Recommend Favorite